The CEO's open-market buy after earnings is a modest confidence signal, but the dollar amount is too small to drive stock movement. Monitor for any larger insider accumulation or changes in institutional ownership. The Q2 earnings beat and raised guidance are the more material catalysts.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 17 $373.11entry
- T+1 · 4mo ago +2.44%α +2.61% · $382.23
- T+5 · 4mo ago +1.66%α +2.35% · $379.31
- T+20 · 3mo ago +7.29%α +2.85% · $400.32
- T+60 · 5w ago +13.13%α +8.44% · $422.09
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Elevance Health insiders, including CEO Gail Boudreaux, made open-market purchases totaling $1.37M over two days following the Q2 2026 earnings release. The CEO bought $1.0M worth of shares, and a director bought $366K. However, the total purchase amount represents only ~0.0017% of ELV's $81B market cap, making it a trivial signal.
Key Financial Metrics
Key Facts
- CEO Gail Boudreaux purchased 2,725 shares at ~$367.50 avg, totaling $1,002,230
- Director Ramiro G. Peru purchased 1,000 shares at $366.05, totaling $366,050
- Total insider purchases: $1,368,280, or 0.0017% of $81B market cap
- Purchases occurred 2 days after Q2 2026 earnings (EPS beat by 20%, but revenue growth flat and margins compressed)
Financial Impact
Insider purchases of $1.37M are negligible relative to $81B market cap; no material financial impact
Risk Factors
- Insider buying is trivial in size and may not reflect a strong conviction signal
- Q2 earnings showed declining GAAP EPS (-13% YoY) and margin compression, which could weigh on the stock
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ELV-1784316092275 |
Track record
19 reports on ELV
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 2/10 Entry $429.48 Now $446.28 +3.91% settles Nov 18
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
- Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Sep 10, 20269w ago 8-K Neutral 3/10 Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
- Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
- Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
- Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers